This submission is Oregon's response to CDC's Emerging Infections Programs Announcement (Funding Opportunity Number CDC-RFA-CK17-1701). In this application, the Public Health Division of the Oregon Health Authority requests continued funding for its Emerging Infections Program (EIP), which has been operating since 1995. The goals of the EIP are to assist in the monitoring, control and prevention of infectious diseases through the rigorous collection of population-based surveillance data, identification of risk factors, and evaluation of the effectiveness of control efforts. Core activities include 1) Scientific, programmatic, and business oversight and coordination; conduct of activities in defined populations; maintaining flexibility and efficiency to respond to emerging public-health issues; collaborations with partners in other EIP sites and in academia; public-health training; management and dissemination of data; developing interoperable information systems to support EIP activities; ensuring a supply of laboratory specimens for phenotypic testing; program evaluation; protection of human subjects; and compliance with federal rules regarding paperwork and dual use research of concern.
In addition to funding for these core activities, Oregon requests funding for the following specific activities:
• Active Bacterial Core surveillance, including surveillance for legionellosis and pertussis
• Foodborne Diseases Active Surveillance Network (FoodNet)
• Influenza and other respiratory disease activities
• Healthcare-Associated Infections — Community Interface, including surveillance for Clostridium difficile infection, candidemia, and infection by antimicrobial-resistant microorganisms
• Human Papillomavirus Vaccine Impact Monitoring Project
• Prion Disease Activities
Funds will be used to hire epidemiology and laboratory staff; to train Oregon Health and Science University (OHSU) infectious disease fellows in applied epidemiology; to contract with OHSU and the Multnomah County Health Department for additional work as needed to address emerging issues; to develop and maintain robust surveillance information systems; to collect and test clinical specimens for public health purposes; and to conduct epidemiologic research.